High Outlier
Strength
150 mg/1
Manufacturer
AstraZeneca Pharmaceuticals LPNDC
00310028160
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
10/22/2025
Active Ingredients
QUETIAPINE FUMARATEApproval Type
New Drug (NDA)
FDA Application
NDA022047On Market Since
2/1/2009
Pharmacological Classes
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
RISPERDAL 0.5 MG TABLET
Brand
50458030201•Janssen Pharmaceuticals Inc.
$4.3928
per EA
RISPERDAL 0.5 MG TABLET
Brand
50458030206•Janssen Pharmaceuticals Inc.
$4.3928
per EA
RISPERDAL 1 MG TABLET
Brand
50458030001•Janssen Pharmaceuticals Inc.
$4.6958
per EA
RISPERDAL 1 MG TABLET
Brand
50458030006•Janssen Pharmaceuticals Inc.
$4.6958
per EA
RISPERDAL 1 MG/ML SOLUTION
Brand
50458030503•Janssen Pharmaceuticals Inc.
$5.2507
per ML
CLOZARIL 25 MG TABLET
Brand
69809012605•HLS Therapeutics (USA), Inc.
$6.2959
per EA
RISPERDAL 2 MG TABLET
Brand
50458032001•Janssen Pharmaceuticals Inc.
$7.8127
per EA
RISPERDAL 2 MG TABLET
Brand
50458032006•Janssen Pharmaceuticals Inc.
$7.8127
per EA
RISPERDAL 3 MG TABLET
Brand
50458033006•Janssen Pharmaceuticals Inc.
$9.1849
per EA
RISPERDAL 4 MG TABLET
Brand
50458035001•Janssen Pharmaceuticals Inc.
$12.4115
per EA